[@b1-ehp0115-a00238] rightly recommended international long-term studies of all potential health effects among the populations exposed to Chernobyl fallout. In the meanwhile, data on post-Chernobyl health detriment in the former Soviet Union and exposed parts of Europe, including evidence of association with such contamination, are already accessible, mostly electronically. Three mutually consistent findings, in particular, challenge widely publicized conclusions the World Health Organization ([@b23-ehp0115-a00238], [@b24-ehp0115-a00238]) (after approval by the International Atomic Energy Agency), and the United Nations Scientific Committee on the Effects of Atomic Radiation ([@b22-ehp0115-a00238]).

First, scientists from the Moscow Kurchatov Institute presented physical evidence that the dominant sources of energy released by the exploding reactor were not the officially assumed thermal explosions ([@b6-ehp0115-a00238]) but rather very low-yield nuclear chain reactions in heavy elements, combined with chemical reactions ([@b3-ehp0115-a00238]). Thus, contrary to the assumed emission of 50 million Ci into the atmosphere (i.e., an estimated 3.5% of the radioactive inventory of the destroyed fuel elements, leaving over 90% of it in the "sarcophagus"), these scientists conclude a 26-fold larger release of radioactivity, leaving no more than 10--15% of the inventory behind. A 26-fold increase would mean that population exposures from the worldwide fallout was in fact more than an order of magnitude larger than assumed by [@b22-ehp0115-a00238]. This would explain a variety of observed health effects that are not to be expected at currently assumed doses ([@b4-ehp0115-a00238]; [@b6-ehp0115-a00238]; [@b8-ehp0115-a00238]).

Second, the WHO accepted the conclusions by UNSCEAR that exposures of populations in the neighboring contaminated regions were of the order of 10 mSv, except for higher thyroid doses from ^131^I ([@b22-ehp0115-a00238]; [@b23-ehp0115-a00238], [@b24-ehp0115-a00238]). The main contributions to dose in other tissues---externally and internally---have been assumed to come from ^137^Cs and ^134^Cs, whereas exposures from other radioisotopes, such as ^90^Sr and ^239^Pu, or other alpha emitters were presumed negligible beyond distances of about 100 km from the plant ([@b6-ehp0115-a00238]; [@b22-ehp0115-a00238]; [@b23-ehp0115-a00238], [@b24-ehp0115-a00238]).

However, direct biological dosimetry contradicts these official estimates. Several research teams investigated radiation-specific cytogenic alterations in the lymphocytes of about 1,000 exposed persons immediately after the accident and/or some years later ([@b20-ehp0115-a00238]; [@b21-ehp0115-a00238]). The majority of these studies revealed that the rate of unstable and stable chromosome aberrations was about 10--100 times higher than would be expected at UNSCEAR's estimated exposure levels ([@b22-ehp0115-a00238]). Biological dosimetry is, however, consistent with the evidence for a much larger release of radioactivity in the explosion. Furthermore, multiaberrant cells, characteristic for incorporated alpha emitters, were identified well beyond 100 km from Chernobyl, whereas plutonium particles were found as far away as Norway, contradicting "negligible exposure levels" beyond 100 km \[[@b11-ehp0115-a00238]; [@b20-ehp0115-a00238]; [@b21-ehp0115-a00238]\]. Currently adopted models for Chernobyl dose estimates ignore contributions from alpha emissions even though they are known to have relative biological effectiveness (RBE) about 20 times larger than that of most radioactive beta and gamma radiation ([@b6-ehp0115-a00238]; [@b10-ehp0115-a00238]; [@b22-ehp0115-a00238]).

Third, excess infant (perinatal) mortality and teratogenic effects were observed in Germany, Poland, and the former Soviet Union shortly after the Chernobyl explosion \[[@b5-ehp0115-a00238]; [@b7-ehp0115-a00238]; [@b12-ehp0115-a00238], [@b13-ehp0115-a00238]; [@b19-ehp0115-a00238]; [@b20-ehp0115-a00238]\]. Excess malformations, childhood morbidity, and genetic effects were reported from several areas of Central Europe and Turkey ([@b4-ehp0115-a00238]; [@b5-ehp0115-a00238]; [@b6-ehp0115-a00238]; [@b15-ehp0115-a00238]; [@b18-ehp0115-a00238]; [@b20-ehp0115-a00238]). These post-Chernobyl observations are consistent with those in the United Kingdom, the United States, and West Germany following the atmospheric nuclear bomb tests of the 1950s ([@b14-ehp0115-a00238]; [@b25-ehp0115-a00238]). According to the [@b10-ehp0115-a00238], [@b22-ehp0115-a00238], and other radiation authorities, teratogenic effects should not occur below a dose threshold of about 100 mSv. However, official estimates of fetal doses after the Chernobyl explosion, even in the most contaminated regions of Germany, were \< 1 mSv ([@b22-ehp0115-a00238]), far below the presumed safe threshold. Thus, either the fetus is much more sensitive to radiation than officially assumed, or the estimated post-Chernobyl fetal doses are far too low (which is consistent with considerably higher radioactive releases), or, most likely, there is a combination of both.

In the absence of scientifically convincing evidence rebutting such challenges to official assessments of the physical events and long-term human consequences of the Chernobyl catastrophe, the Precautionary Principle in public health issues ([@b9-ehp0115-a00238]; [@b16-ehp0115-a00238]) requires that these unwelcome findings be no longer ignored in "state of knowledge" reviews ([@b2-ehp0115-a00238]; [@b17-ehp0115-a00238]), in "assessments of the health consequences" ([@b1-ehp0115-a00238]), and in official radiation protection standards.

[^1]: The author declares he has no competing financial interests.
